Literature DB >> 36001283

Surgical pathology of adenocarcinomas arising around or within the gastroesophageal junction.

Bastian Dislich1, Dino Kröll2,3, Rupert Langer4,5.   

Abstract

Classification of adenocarcinomas (AC) arising around or within the gastroesophageal junction (GEJ) is hampered by major morphologic and phenotypic overlaps. We reviewed the surgical pathology of esophagectomy specimens of 115 primary resected AC of the esophagus as defined by the 5th edition of the WHO classification regarding the anatomical site of the tumor, with corresponding categorization according to the Siewert AEG Classification and the preceding 4th edition of the WHO (discriminating esophageal adenocarcinomas/EAC and adenocarcinomas of the gastroesophageal junction/AdGEJ), and further histology findings. In addition, immunohistochemistry (IHC) for CDX2, CK7, CK20, MUC2, MUC5AC and MUC6 was performed. Sixty-eight cases were Siewert AEG type I and 47 cases Siewert AEG type II. Out of the AEG I tumors, 26 were classified as AdGEJ. Regardless of the classification system, more proximally located tumors showed less aggressive behavior with lower rates of lymph node metastases, lymphatic, venous and perineural invasion, better histological differentiation (p < 0.05 each) and were more frequently associated with pre-neoplastic Barrett's mucosa (p < 0.001). Histologically, the tumors displayed intestinal morphology in the majority of cases. IHC showed non-conclusive patterns with a frequent CK7+/CK20+ immunophenotype in all tumors, but also a gastric MUC5AC+ and MUC6+ phenotype in some proximal tumors. In conclusion, histology of the tumors and IHC failed to distinguish reliably between more proximal and more distal tumors. The presence of Barrett's mucosa rather than location alone, however, may help to further differentiating adenocarcinomas arising in this region and may be indicative for a particular biologic type.
© 2022. The Author(s).

Entities:  

Keywords:  Adenocarcinoma; Biomarker; Esophagus; Gastroesophageal junction; Intestinal metaplasia; Surgical pathology

Year:  2022        PMID: 36001283     DOI: 10.1007/s13304-022-01360-z

Source DB:  PubMed          Journal:  Updates Surg        ISSN: 2038-131X


  11 in total

1.  THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO-CALLED INTESTINAL-TYPE CARCINOMA. AN ATTEMPT AT A HISTO-CLINICAL CLASSIFICATION.

Authors:  P LAUREN
Journal:  Acta Pathol Microbiol Scand       Date:  1965

2.  Identification of the distinct genomic features in gastroesophageal junction adenocarcinoma and its Siewert subtypes.

Authors:  Qirong Geng; Jiawen Lao; Xiaoyu Zuo; Shangxiang Chen; Jin-Xin Bei; Dazhi Xu
Journal:  J Pathol       Date:  2020-10-02       Impact factor: 7.996

3.  Classification of adenocarcinoma of the oesophagogastric junction.

Authors:  J R Siewert; H J Stein
Journal:  Br J Surg       Date:  1998-11       Impact factor: 6.939

4.  Adenocarcinoma of the esophago-gastric junction.

Authors:  J R Siewert; H J Stein; M Feith
Journal:  Scand J Surg       Date:  2006       Impact factor: 2.360

5.  Expression patterns of programmed death-ligand 1 in esophageal adenocarcinomas: comparison between primary tumors and metastases.

Authors:  Bastian Dislich; Alexandra Stein; Christian A Seiler; Dino Kröll; Sabina Berezowska; Inti Zlobec; José Galvan; Julia Slotta-Huspenina; Axel Walch; Rupert Langer
Journal:  Cancer Immunol Immunother       Date:  2017-03-13       Impact factor: 6.968

6.  Impact of peritumoral and intratumoral budding in esophageal adenocarcinomas.

Authors:  Svenja Thies; Lars Guldener; Julia Slotta-Huspenina; Inti Zlobec; Viktor H Koelzer; Alessandro Lugli; Dino Kröll; Christian A Seiler; Marcus Feith; Rupert Langer
Journal:  Hum Pathol       Date:  2016-02-10       Impact factor: 3.466

Review 7.  The 4th St. Gallen EORTC Gastrointestinal Cancer Conference: Controversial issues in the multimodal primary treatment of gastric, junctional and oesophageal adenocarcinoma.

Authors:  Manfred P Lutz; John R Zalcberg; Michel Ducreux; Antoine Adenis; William Allum; Daniela Aust; Fatima Carneiro; Heike I Grabsch; Pierre Laurent-Puig; Florian Lordick; Markus Möhler; Stefan Mönig; Radka Obermannova; Guillaume Piessen; Angela Riddell; Christoph Röcken; Franco Roviello; Paul Magnus Schneider; Stefan Seewald; Elizabeth Smyth; Eric van Cutsem; Marcel Verheij; Anna Dorothea Wagner; Florian Otto
Journal:  Eur J Cancer       Date:  2019-03-15       Impact factor: 9.162

8.  High intratumoural but not peritumoural inflammatory host response is associated with better prognosis in primary resected oesophageal adenocarcinomas.

Authors:  Alexandra V Stein; Bastian Dislich; Annika Blank; Lars Guldener; Dino Kröll; Christian A Seiler; Rupert Langer
Journal:  Pathology       Date:  2016-12-02       Impact factor: 5.306

Review 9.  Current surgical treatment standards for esophageal and esophagogastric junction cancer.

Authors:  Minoa K Jung; Thomas Schmidt; Seung-Hun Chon; Mickael Chevallay; Felix Berlth; Junichi Akiyama; Christian A Gutschow; Stefan P Mönig
Journal:  Ann N Y Acad Sci       Date:  2020-08-14       Impact factor: 5.691

10.  Transcriptomic profiling reveals three molecular phenotypes of adenocarcinoma at the gastroesophageal junction.

Authors:  Jan Bornschein; Lorenz Wernisch; Maria Secrier; Ahmad Miremadi; Juliane Perner; Shona MacRae; Maria O'Donovan; Richard Newton; Suraj Menon; Lawrence Bower; Matthew D Eldridge; Ginny Devonshire; Calvin Cheah; Richard Turkington; Richard H Hardwick; Michael Selgrad; Marino Venerito; Peter Malfertheiner; Rebecca C Fitzgerald
Journal:  Int J Cancer       Date:  2019-05-17       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.